Literature DB >> 26927671

Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation.

Samantha E Adamson, Rachael Griffiths, Radim Moravec, Subramanian Senthivinayagam, Garren Montgomery, Wenshu Chen, Jenny Han, Poonam R Sharma, Garrett R Mullins, Stacey A Gorski, Jonathan A Cooper, Alexandra Kadl, Kyle Enfield, Thomas J Braciale, Thurl E Harris, Norbert Leitinger.   

Abstract

Acute and chronic tissue injury results in the generation of a myriad of environmental cues that macrophages respond to by changing their phenotype and function. This phenotypic regulation is critical for controlling tissue inflammation and resolution. Here, we have identified the adaptor protein disabled homolog 2 (DAB2) as a regulator of phenotypic switching in macrophages. Dab2 expression was upregulated in M2 macrophages and suppressed in M1 macrophages isolated from both mice and humans, and genetic deletion of Dab2 predisposed macrophages to adopt a proinflammatory M1 phenotype. In mice with myeloid cell-specific deletion of Dab2 (Dab2fl/fl Lysm-Cre), treatment with sublethal doses of LPS resulted in increased proinflammatory gene expression and macrophage activation. Moreover, chronic high-fat feeding exacerbated adipose tissue inflammation, M1 polarization of adipose tissue macrophages, and the development of insulin resistance in DAB2-deficient animals compared with controls. Mutational analyses revealed that DAB2 interacts with TNF receptor-associated factor 6 (TRAF6) and attenuates IκB kinase β-dependent (IKKβ-dependent) phosphorylation of Ser536 in the transactivation domain of NF-κB p65. Together, these findings reveal that DAB2 is critical for controlling inflammatory signaling during phenotypic polarization of macrophages and suggest that manipulation of DAB2 expression and function may hold therapeutic potential for the treatment of acute and chronic inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26927671      PMCID: PMC4811113          DOI: 10.1172/JCI79590

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide.

Authors:  J Lee; L Mira-Arbibe; R J Ulevitch
Journal:  J Leukoc Biol       Date:  2000-12       Impact factor: 4.962

2.  Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion.

Authors:  Frank Rosenbauer; Axel Kallies; Marina Scheller; Klaus-Peter Knobeloch; Charles O Rock; Maike Schwieger; Carol Stocking; Ivan Horak
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2.

Authors:  S M Morris; J A Cooper
Journal:  Traffic       Date:  2001-02       Impact factor: 6.215

4.  p67 isoform of mouse disabled 2 protein acts as a transcriptional activator during the differentiation of F9 cells.

Authors:  S Y Cho; J W Jeon; S H Lee; S S Park
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

5.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.

Authors:  H Sakurai; H Chiba; H Miyoshi; T Sugita; W Toriumi
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

6.  Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport.

Authors:  Shelli M Morris; Michelle D Tallquist; Charles O Rock; Jonathan A Cooper
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

7.  Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin.

Authors:  A V Oleinikov; J Zhao; S P Makker
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

8.  Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).

Authors:  Z Sheng; J He; J A Tuppen; W Sun; Z Fazili; E R Smith; F B Dong; X X Xu
Journal:  Genomics       Date:  2000-12-15       Impact factor: 5.736

9.  Crystal structures of the Dab homology domains of mouse disabled 1 and 2.

Authors:  Mikyung Yun; Lakhu Keshvara; Cheon-Gil Park; Yong-Mei Zhang; J Bradley Dickerson; Jie Zheng; Charles O Rock; Tom Curran; Hee-Won Park
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

10.  Regulation of the Wnt signaling pathway by disabled-2 (Dab2).

Authors:  B A Hocevar; F Mou; J L Rennolds; S M Morris; J A Cooper; P H Howe
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  24 in total

1.  Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.

Authors:  Samantha E Adamson; Renata Polanowska-Grabowska; Kathryn Marqueen; Rachael Griffiths; Jerry Angdisen; Sarah R Breevoort; Ira G Schulman; Norbert Leitinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

2.  A Novel Subset of Anti-Inflammatory CD138+ Macrophages Is Deficient in Mice with Experimental Lupus.

Authors:  Shuhong Han; Haoyang Zhuang; Stepan Shumyak; Jingfan Wu; Hui Li; Li-Jun Yang; Westley H Reeves
Journal:  J Immunol       Date:  2017-07-10       Impact factor: 5.422

3.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

4.  Myeloid P2Y2 receptor promotes acute inflammation but is dispensable for chronic high-fat diet-induced metabolic dysfunction.

Authors:  Samantha E Adamson; Garren Montgomery; Scott A Seaman; Shayn M Peirce-Cottler; Norbert Leitinger
Journal:  Purinergic Signal       Date:  2017-10-30       Impact factor: 3.765

5.  Disabled-2 is a negative immune regulator of lipopolysaccharide-stimulated Toll-like receptor 4 internalization and signaling.

Authors:  Wei-Shan Hung; Pin Ling; Ju-Chien Cheng; Shy-Shin Chang; Ching-Ping Tseng
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

Review 6.  The Spleen: A Hub Connecting Nervous and Immune Systems in Cardiovascular and Metabolic Diseases.

Authors:  Andrea Lori; Marialuisa Perrotta; Giuseppe Lembo; Daniela Carnevale
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

Review 7.  Targeting Macrophages in Cancer: From Bench to Bedside.

Authors:  Ashleigh R Poh; Matthias Ernst
Journal:  Front Oncol       Date:  2018-03-12       Impact factor: 6.244

8.  TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity.

Authors:  Wenyu Fu; Wenhuo Hu; Young-Su Yi; Aubryanna Hettinghouse; Guodong Sun; Yufei Bi; Wenjun He; Lei Zhang; Guanmin Gao; Jody Liu; Kazuhito Toyo-Oka; Guozhi Xiao; David B Solit; Png Loke; Chuan-Ju Liu
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 14.808

Review 9.  Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.

Authors:  Wensi Tao; Robert Moore; Elizabeth R Smith; Xiang-Xi Xu
Journal:  Front Cell Dev Biol       Date:  2016-11-25

Review 10.  Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.

Authors:  Weitao Zhang; Jiawei Li; Guisheng Qi; Guowei Tu; Cheng Yang; Ming Xu
Journal:  J Transl Med       Date:  2018-01-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.